Iron, aspirin, and heart disease risk
Sullivan, J.L.
JAMA 247(6): 751
1982
ISSN/ISBN: 0098-7484 PMID: 7057546 Document Number: 183407
Document emailed within 1 workday
Related Documents
Elwood, P.C. 2001: Reducing the risk: heart disease, stroke and aspirin Journal of the Medical Association of Thailand 84(8): 1164-1174Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
1980: Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group Circulation 62(3): 449-461
Wu, X.G. 1983: Multivariate analysis of the risk factors of coronary heart disease among 988 male workers at a capital iron and steel complex Zhonghua Xin Xue Guan Bing Za Zhi 11(1): 28-32
Gupta, R.; Rastogi, S.; Nagar, R.; Kastia, S.; Kaul, V. 2000: Dietary and serum iron, body iron stores and coronary heart disease Journal of the Association of Physicians of India 48(5): 489-492
Constantine, G.R.; Thenabadu, P.N. 1996: Use of aspirin in ischaemic heart disease Ceylon Medical Journal 41(4): 167-168
Rus, H.; Niculescu, F.I. 1997: Inflammation, aspirin, and the risk of cardiovascular disease New England Journal of Medicine 337(6): 423; Author Reply 423-424
Canner, P.L. 1983: Aspirin in coronary heart disease. Comparison of six clinical trials Israel Journal of Medical Sciences 19(5): 413-423
O'Connor, P.J.; Pronk, N.P.; Tan, A.W.; Rush, W.A.; Gray, R.J. 1998: Does professional advice influence aspirin use to prevent heart disease in an HMO population? Effective Clinical Practice: Ecp 1(1): 26-32
Lindbloom, E.J.; Eaton, L.J. 2002: Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease Journal of Family Practice 51(9): 789
Jain, A.; Mehrotra, T.N.; Goel, V.K.; Mehrotra, M.L.; Raka, M.S. 1982: Effect of aspirin on plasma fibrinolytic activity in patients of coronary heart disease Journal of the Association of Physicians of India 30(7): 441-443
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Bar Dayan, Y.; Amital, H.; Levy, Y.; Shoenfeld, Y. 1996: Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction Israel Journal of Medical Sciences 32(5): 288-291
Born, G.V. 1990: Anti-thrombotic drugs in the treatment of coronary heart disease: the present situation with aspirin Zeitschrift für Kardiologie 79(Suppl 3): 147-150
Engle-Stone, R.; Nankap, M.; Ndjebayi, A.O.; Erhardt, J.G.; Brown, K.H. 2013: Plasma ferritin and soluble transferrin receptor concentrations and body iron stores identify similar risk factors for iron deficiency but result in different estimates of the national prevalence of iron deficiency and iron-deficiency anemia among women and children in Cameroon Journal of Nutrition 143(3): 369-377
Sattar, N.; Welsh, P.; Sarwar, N.; Danesh, J.; Di Angelantonio, E.; Gudnason, V.; Davey Smith, G.; Ebrahim, S.; Lawlor, D.A. 2010: NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study Atherosclerosis 209(1): 295-299
de Gaetano, G. 2001: Aspirin and the prevention of ischemic heart disease. A Socratic dialogue between a cardiologist, a clinical pharmacologist and an expert of blood platelets Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(8): 582-588
Sullivan, J.L. 1994: Effects of dietary iron intake on stored iron, free iron, and coronary disease Circulation 90(6): 3122-3123
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Liu, H.; Chen, Z.; Gao, R. 1995: Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease Zhonghua Nei Ke Za Zhi 34(9): 595-598